# Regenimo Biosciences, Inc. — Form D

Regenimo Biosciences, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2025-11-25. The offering totals $2.0M, of which $2.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-11-25
- Form: D
- Accession: 0002096367-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $2.0M
- Minimum investment: $50K
- Investors: 6
- Date of first sale: 2025-11-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-564953

## Issuer

- Name: Regenimo Biosciences, Inc.
- CIK: 0002096367
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 3262 WESTHEIMER RD. #762, HOUSTON, TX, 77098
- Phone: 7137022100

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Lynda Chin | Director | Houston, TX |
| Raju Kucherlapati | Director | Houston, TX |
| Sharon Shacham | Director | TEL AVIV, L3 |
| Sharon Shacham | Executive Officer | TEL AVIV, L3 |

## More

- [CIK 2096367 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2096367&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002096367-25-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.